The company has built multiple technology platforms to better serve its customers:
--We have established the library of hundreds of oxidoreductase and transaminase and developed dozens of commercialized green synthesis processes to support cost reduction, efficiency and safe production of products;
--Heterocyclic compounds are difficult to synthesize and have high technical barriers, we have established a comprehensive library of spirocyclic molecules to meet the needs of our customers at the R&D and commercialization stages;
--Lipid chain series play an important role in drug delivery and structural modification, and we have developed a lipid series of compounds based on long-acting insulin and GLP-1 side chains;
--Provide intermediates for each step of API.